Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6Y6S

Mouse Galactocerebrosidase complexed with galacto-noeurostegine GNS at pH 6.8

6Y6S の概要
エントリーDOI10.2210/pdb6y6s/pdb
分子名称Galactocerebrosidase, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, (1~{R},2~{S},3~{S},4~{R},5~{R})-4-(hydroxymethyl)-8-azabicyclo[3.2.1]octane-1,2,3-triol, ... (7 entities in total)
機能のキーワードinhibitor, hydrolase
由来する生物種Mus musculus (House mouse)
タンパク質・核酸の鎖数1
化学式量合計76379.14
構造登録者
Deane, J.E.,McLoughlin, J. (登録日: 2020-02-27, 公開日: 2021-01-13, 最終更新日: 2024-10-16)
主引用文献Viuff, A.,Salamone, S.,McLoughlin, J.,Deane, J.E.,Jensen, H.H.
The Bicyclic Form of galacto -Noeurostegine Is a Potent Inhibitor of beta-Galactocerebrosidase.
Acs Med.Chem.Lett., 12:56-59, 2021
Cited by
PubMed Abstract: Competitive inhibitors of galactocerebrosidase (GALC) could be candidates for pharmacological chaperone therapy of patients with Krabbe disease. The known and selective nortropane-type iminosugar -noeurostegine has been found to competitively inhibit GALC with = 7 μM at pH 4.6, which is 330-fold more potent than the analogous deoxynoeurostegine. It was shown through X-ray protein crystallography that -noeurostegine binds to the active site of GALC in its bicyclic form.
PubMed: 33488964
DOI: 10.1021/acsmedchemlett.0c00377
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.1 Å)
構造検証レポート
Validation report summary of 6y6s
検証レポート(詳細版)ダウンロードをダウンロード

227344

件を2024-11-13に公開中

PDB statisticsPDBj update infoContact PDBjnumon